What is Basaglar KiwkPen: Uses, Warnings & Interactions

Updated May 14, 2025  •  Published Dec 31, 2020

Basaglar Kwikpen is a multiple-dose pen injector filled with long-acting insulin glargine. Once-daily injections help keep basal insulin steady throughout the day to provide ongoing control of blood sugar. Doctors prescribe it to both adults and children with diabetes mellitus. Doses are injected once daily at the same time every day.

Basaglar KiwkPen overview

BRAND NAMES:

  • Basaglar KwikPen

Generic Names:

  • Insulin glargine

Uses:

  • Treats diabetes

Therapeutic Classes:

  • Antidiabetic, long-acting human insulin

Forms:

  • Injectable

How it’s taken:

  • By injection

What is Basaglar KiwkPen used for?

Basaglar Kwikpen is a pen injector prefilled with a synthetic long-acting insulin. Doctors prescribe it to control blood sugar levels throughout the day in adults and children with Type 1 diabetes and adults with Type 2 diabetes.

What form(s) does Basaglar KiwkPen come in

  • Injection pen 

    • 3 mL of 100 unit/mL

What are common Basaglar KiwkPen doses?

  • For Type 1 diabetes:

    • In adults: Doses will vary; injections are administered once daily at the same time every day

    • In children 6 years of age and older: Doses will vary; injections are administered once daily at the same time every day

  • For Type 2 diabetes in adults: Doses will vary but start at 0.2 units/kg up to a maximum of 10 units daily; injections are administered once daily at the same time every day

Common Basaglar KiwkPen prescriptions

  • Basaglar KwikPen
    3ml of 100unit/ml pen

How to take Basaglar KiwkPen

  • Follow all directions given by the prescriber and healthcare team. 

  • Please read the Patient Information sheet that comes included with the pen.

  • Give one injection daily at the same time every day.

  • A healthcare provider will demonstrate how to administer an injection and where on the body to make an injection.

  • Read and follow the illustrated Instructions for Use that come with the KwikPen. 

  • A caregiver should administer KwikPen injections for people who are blind or have vision problems.

  • How to prepare the Basaglar KwikPen for an injection:

    • Inspect the pen to make sure it contains the correct insulin, is undamaged, and that the medicine is clear, colorless, and free from particles. 

    • Do not use the KwikPen if it is damaged or if the medicine is cloudy, discolored, or has floating particles.

    • Attach the needle to the pen. Always use a new needle for each injection.

    • Prime the pen as outlined in the Instructions for Use. 

    • Select the dose on the pen. 

    • The pen can only give doses as large as 80 units. If your dose is larger than 80 units, you will need to use two injections to complete the entire dose.

  • How to prepare the skin for an injection:

    • Injections are made into the skin. Do not inject insulin into a muscle or a vein.

    • Injections are given in the stomach area, buttocks, upper thigh, or upper arm. Use a different area of the body for each injection.

    • Do not inject insulin into bruised, hard, scaly, tender, or scarred skin. 

    • Wash your hands.

    • Wipe the skin with an alcohol swab. Let dry.

  • How to administer an injection:

    • Holding the pen perpendicular to the skin, insert the needle into the skin.

    • Press the Dose Knob all the way in. Do not turn the knob.

    • Keep the needle inserted while you slowly count to five.

    • Pull the needle from the skin.

    • Check the dose window. It should read “0.”

    • If it does not read “0,” do not redial the dose. Insert the needle and press the dose knob again.

    • If it still does not read “0,” do not try to give another dose. Monitor blood sugar for the rest of the day. 

    • Carefully replace the outer needle shield. 

    • Unscrew the capped needle from the injector and dispose of it in a sharps container.

  • Store unused KwikPens in the refrigerator (36°F to 46°F). Do not freeze. Dispose of the medicine if it freezes.

  • Store in-use KwikPens at room temperature (up to 86°F), protected from heat and light.

  • In-use KwikPens can be stored and reused for up to 28 days. After 28 days, dispose of any unused medicine.

  • Protect the KwikPen from light. 

  • Keep KwikPens out of the reach and sight of children.

What to do if you miss a dose of Basaglar KiwkPen

  • The prescriber or healthcare team should provide a plan for managing missed doses. If not, ask for one and follow that plan.

  • The prescriber or healthcare team may advise that a missed dose: 

    • Be taken within a specified number of hours after its regular time

    • Be replaced by a remedial dose (lower dose) to be taken within a specified number of hours after the dose is missed

    • Be skipped entirely, blood sugar be regularly monitored, and high blood sugar be managed with fast-acting insulin

  • If you don’t have clear instructions from the healthcare team, call or visit a doctor or urgent care.

  • If a Basaglar dose is not taken, test blood sugar levels throughout the day.

  • Never take two doses of insulin to make up for a missed dose.

Basaglar KiwkPen contraindications

  • This medicine is not right for everyone. 

  • Do not use it if you have had an allergic reaction to insulin glargine.

  • Do not use Basaglar during hypoglycemic (low blood sugar) episodes.

Basaglar KiwkPen warnings

  • Insulin treatment requires regular check-ups and blood tests to make sure the dose is correct and that there are no side effects. Keep all appointments.

  • Make sure other doctors and other healthcare providers know you’re taking insulin. 

  • Tell the prescriber if you are pregnant, planning to become pregnant, or breastfeeding.

  • The prescriber needs to know all your medical conditions before and during insulin treatment, particularly:

    • Kidney problems

    • Liver problems

  • Dietary and lifestyle changes can affect blood sugar levels and require changing insulin doses. Inform the prescriber about significant changes such as:

    • Dietary changes

    • Increase or decrease in physical activity or exercise

    • Increased stress

    • Illness

    • Injury

    • Upcoming or recent surgery

    • New drugs or discontinued drugs

  • The most common side effect of insulin treatment is low blood sugar (hypoglycemia). The prescriber will teach you the signs and symptoms of low blood sugar. When these occur, follow the treatment steps given to you by your healthcare team.

  • Because hypoglycemia is a common side effect, people on insulin often experience accidents and injuries. Do not drive or engage in any other risky activity until you know you are stabilized on your insulin dose. 

  • Insulin treatment can also lower potassium levels. Review the clinical signs of low potassium (hypokalemia) with the prescriber and call a healthcare professional if they occur.

  • Never share the Basaglar KwikPen or needles with other people.

Basaglar KiwkPen interactions

  • Make sure the prescriber knows about all the prescription drugs, over-the-counter medications, and supplements you use, particularly:

  • Talk to your diabetes doctor when you start or stop a new drug or supplement.

  • Do not drink alcohol or use medications containing alcohol when taking insulin.

Basaglar KiwkPen side effects

Serious Side Effects

Talk to the prescriber if you notice any signs or symptoms of a possible serious side effect of Basaglar, including:

  • Dizziness, lightheadedness, sweating, confusion, headache, blurred vision, slurred speech, shaking, racing heartbeats, anxiety, irritability, other mood changes 

  • Muscle twitches, muscle weakness, palpitations, fatigue, numbness or tingling

  • Shortness of breath, swollen ankles or feet, sudden weight gain

  • Trouble breathing, shortness of breath, fast heartbeat, sweating, extreme drowsiness, dizziness, confusion

  • Allergic reaction: Whole body rash, trouble breathing, racing heartbeats, sweating, swelling of the face or tongue 

Less Serious Side Effects

  • Low blood sugar

  • Weight gain

  • Injection site reactions such as redness or discomfort

  • Skin thickening or pits at the injection site

Sources:

Subscribe to our savings newsletter

Health education, drug info, wellness & more

By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.